drugset / Trial / NCT01504477
Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
Panitumumab plus bortezomib for colon cancer
Timeline
- Start
- 2011-12
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | Intravenous |
| Subject | Panitumumab | Monoclonal antibody | 6 mg/kg | Intravenous |